Papers, abstracts, presentations, posters and webcasts emanating from the audit
Webcast presented by Professor Hugh Jones at the EASD Hamburg, September 2023. H. Jones, K. Darzy, R. Troke, U. Dashora, A. Haider, R. Ryder. Testosterone replacement in men with type 2 diabetes lowers HbA1c : ABCD worldwide audit.
Webcast: https://www.youtube.com/watch?v=B315Dwj9jsU
EASD interview with Professor Jones: https://youtu.be/iG8N4sNq2Ks
ATTD 2025 Hugh Jones, Karim Haider, Ahmed Haider, Umesh Dashora, Robert Ryder. Testosterone replacement therapy improves glycaemic control and symptoms of hypogonadism in men with type 2 diabetes – The ABCD worldwide audit. EPV317 / #1231 E-Poster Viewing Topic: AS11. Diabetes Technology & Therapeutics Volume 27, Issue S2 March 2025. Abstract 1231, page e276.
https://liebertpub.com/doi/epub/10.1089/dia.2024.78502.abstracts
https://doi.org/10.1089/dia.2024.78502.abstracts
DUK 2025 TH Jones, A Haider, KS Haider, U Dashora, REJ Ryder. Testosterone therapy improves quality of life and sexual health replacement in hypogonadal men with type 2 diabetes: The Association of British Clinical Diabetologists (ABCD) worldwide audit.
Diabetic Medicine, Abstracts of the Diabetes UK Professional Conference 2025, SEC Glasgow, 26‐28 February 2025. P108 (Page 83).
https://doi.org/10.1111/dme.15498
https://onlinelibrary.wiley.com/doi/epdf/10.1111/dme.15498
ADA 2024 Thomas H. Jones, Ahmad Haider, Karim Sultan Haider, Melissa L. Cull, Robert E. Ryder; 895-P: Testosterone Replacement Therapy in Men with Hypogonadism and Type 2 Diabetes—ABCD Worldwide Audit. Diabetes 14 June 2024; 73 (Supplement_1): 895–P. https://doi.org/10.2337/db24-895-P
EASD 2023 H. Jones, K. Darzy, R. Troke, U. Dashora, A. Haider, R. Ryder. Testosterone replacement in men with type 2 diabetes lowers HbA1c : ABCD worldwide audit. Diabetologia 66 (Suppl 1), 1–536 (2023).
Link to Abstract: scroll to abstract 704 https://link.springer.com/article/10.1007/s00125-023-05969-6#Sec109
Posters
ATTD 2025
DUK 2025
ADA 2024
ADA 2024 (ePoster)
EASD 2023
